当代管理失败的Fontan的当代管理
Prashanth Venkatesh1, Hans Gao1, Islam Abudayyeh2
1Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Journal of clinical medicine
|June 19, 2024
概括
患有丰坦循环的成年人,复杂的先天性心脏缺陷,面临严重的并发症. 本综述详细介绍了常见的Fontan循环衰竭问题和当前管理策略,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 成年人的先天性心脏病
- 心血管生理学心血管生理学
背景情况:
- 成人先天性心脏病 (ACHD) 患者数量现在超过了儿科病例,这是由于手术的进步和更好的生存率.
- 丰坦循环是一种复杂的先天性心脏缺陷,经常在成人ACHD人群中出现.
- 患有Fontan循环的患者表现出独特的生理学,使他们容易发生许多并发症.
研究的目的:
- 审查Fontan循环衰竭的常见临床表现 (表型).
- 讨论这些Fontan失败表型的当代管理策略.
- 为管理成年Fontan患者的临床医生提供最新的概述.
主要方法:
- 对当代研究和临床指南的文献综述.
- 关于Fontan循环衰竭表型的信息综合.
- 对Fontan相关并发症当前治疗方法的分析.
主要成果:
- 丰坦循环衰竭的常见表型包括血栓形成,肺血管疾病,心力衰竭,心律不整,膜吐和失去蛋白质的肠病.
- 管理策略是根据特定的表型量身定制的,涉及医疗,干预和手术选择.
- 医疗保健的进步提高了生存率,但需要持续警并发症.
结论:
- 丰顿的循环衰竭呈现出不同的表型,需要在成年人ACHD中进行专业的治疗.
- 当代策略重点关注早期识别和多学科的护理,以减轻与Fontan相关的风险.
- 持续的研究和临床更新对于优化Fontan幸存者的长期结果至关重要.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K


